
Cocrystal Pharma Inc
NASDAQ:COCP

Intrinsic Value
The intrinsic value of one
COCP
stock under the Base Case scenario is
0.69
USD.
Compared to the current market price of 1.57 USD,
Cocrystal Pharma Inc
is
Overvalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cocrystal Pharma Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Cocrystal Pharma Inc
Balance Sheet Decomposition
Cocrystal Pharma Inc
Current Assets | 8.8m |
Cash & Short-Term Investments | 6.9m |
Receivables | 1.4m |
Other Current Assets | 460k |
Non-Current Assets | 1.8m |
Long-Term Investments | 86k |
PP&E | 1.7m |
Free Cash Flow Analysis
Cocrystal Pharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cocrystal Pharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-16.1m
USD
|
Operating Income
|
-16.1m
USD
|
Other Expenses
|
212k
USD
|
Net Income
|
-15.8m
USD
|
COCP Profitability Score
Profitability Due Diligence
Cocrystal Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Cocrystal Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
COCP Solvency Score
Solvency Due Diligence
Cocrystal Pharma Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Score
Cocrystal Pharma Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COCP Price Targets Summary
Cocrystal Pharma Inc
According to Wall Street analysts, the average 1-year price target for
COCP
is 8.5 USD
with a low forecast of 7.07 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for COCP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
COCP
stock under the Base Case scenario is
0.69
USD.
Compared to the current market price of 1.57 USD,
Cocrystal Pharma Inc
is
Overvalued by 56%.